Submission Details
| 510(k) Number | K061404 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 19, 2006 |
| Decision Date | August 07, 2006 |
| Days to Decision | 80 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Statement |
K061404 is an FDA 510(k) clearance for the MONO-CRAWFORD NASO-LACRIMAL INTUBATION DEVICE, a Lacrimal Stents And Intubation Sets, submitted by Fci Ophthalmics, Inc. (Centercille, US). The FDA issued a Cleared decision on August 7, 2006, 80 days after receiving the submission on May 19, 2006. This device falls under the Ophthalmic review panel.
| 510(k) Number | K061404 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 19, 2006 |
| Decision Date | August 07, 2006 |
| Days to Decision | 80 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Statement |
| Product Code | OKS — Lacrimal Stents And Intubation Sets |
| Device Class | — |
| Definition | Lacrimal Stents And Intubations Sets Are Intended To Repair The Lacrimal Drainage System. Lacrimal Stents And Intubations Sets Are Indicated For, But Limited To, The Treatment Of Epiphora In Infants And Adults; Canalicular Pathologies Such As Stenosis; Obstruction Or Laceration; And Conditions Requiring Dacryocystorhinostomy (conventional Or Laser); Or Imperforation Of The Nasolacrimal Duct In An Infant. |